Keywords: gw, pharma, sativex, launched, canada, uk, drugmaker

GW Pharma's Sativex launched in Canada

Article | 27 June 2005

UK drugmaker GW Pharmaceuticals' Sativex, an adjunctive treatment for symptomatic relief of neuropathic pain in adults with multiple sclerosis, is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Go to company listing

Related Drugs

Aspirin

Bayer

Go to drug listing